Evidence map›Paper›PMID 36914771›Full record

ArticleLeukemia2023

Exploring the genetic landscape of HCV-related B-cell lymphomas using whole exome sequencing.

Marine Armand, Michaël Degaud, Bruno Tesson, Cécile Laurent, Manon Vavasseur, Mélanie Parisot, Bénédicte Hoareau-Coudert, Danielle Canioni, Jean Marie Michot, Frédéric Charlotte and 9 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Leukemia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Marine Armand *Hematology Laboratory, Hôpital Pitié-Salpêtrière, Assistance-Publique-Hôpitaux de Paris and Sorbonne University, Paris, France.ORCID http://orcid.org/0000-0001-8906-3128
Michaël Degaud *Hematology Laboratory, Hôpital Pitié-Salpêtrière, Assistance-Publique-Hôpitaux de Paris and Sorbonne University, Paris, France.ORCID http://orcid.org/0000-0002-0582-782X
Bruno TessonBioinformatics Department, LYSARC, Paris, France.
Cécile LaurentBioinformatics Department, LYSARC, Paris, France.ORCID http://orcid.org/0000-0002-3022-2283
Manon VavasseurLaboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, INSERM UMR_S 1163, Imagine Institute, Université Paris Cité, Paris, France.
Mélanie ParisotGenomics Core Facility, Institut Imagine-Structure Fédérative de Recherche Necker, INSERM U1163 et INSERM US24/CNRS UAR3633, Paris Descartes Sorbonne Paris Cité University, Paris, France.
Bénédicte Hoareau-CoudertSorbonne-Université, INSERM, UMS-037 PASS, Cytometry Facility CyPS, Paris, France.ORCID http://orcid.org/0000-0002-6575-7085
Danielle CanioniDepartment of Pathology, Hôpital Necker-Enfants Malades, Assistance-Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France.
Jean Marie MichotGustave Roussy Institute, Département des Innovations Thérapeutiques et Essais Précoces, Université Paris-Saclay, Villejuif, France.
Frédéric CharlotteDepartment of Pathology, Hôpital Pitié-Salpêtrière, Assistance-Publique-Hôpitaux de Paris, Sorbonne University, Paris, France.ORCID http://orcid.org/0000-0003-2803-6606
Véronique MeigninDepartment of Pathology, Hôpital Saint-Louis, Assistance-Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France.
Camille LaurentDepartment of Pathology, CHU de Toulouse, Institut Universitaire du Cancer, Toulouse, France.
Alexandra Traverse-GléhenUniversité Lyon 1, Centre International de Recherche en Infectiologie (CIRI), INSERM U1111, CNRS, UMR5308, ENS Lyon, France.
Diane DamotteDepartment of Pathology, Hôpitaux Universitaire Paris Centre, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France.
Emmanuel BachyDepartment of Hematology, Hospices Civils de Lyon, Claude Bernard Lyon 1 University, Lyon, France.ORCID http://orcid.org/0000-0003-2694-7510
Caroline BessonDepartment of Hematology and Oncology, Centre Hospitalier de Versailles, Le Chesnay, France.ORCID http://orcid.org/0000-0003-4364-7173
Olivier HermineLaboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, INSERM UMR_S 1163, Imagine Institute, Université Paris Cité, Paris, France.
Frédéric DaviHematology Laboratory, Hôpital Pitié-Salpêtrière, Assistance-Publique-Hôpitaux de Paris and Sorbonne University, Paris, France.
Lucile CouronnéLaboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, INSERM UMR_S 1163, Imagine Institute, Université Paris Cité, Paris, France. lucile.couronne@aphp.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hepatitis CLymphoma, Large B-Cell, DiffuseExome SequencingHumans

Identifiers

PMID36914771

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.